Quality Control Tests Of Capsules dosage form.
1. Weight Variation Test
2. Content Uniformity Test
3. Dissolution Test
4. Disintegration Test
5. Leak Test
The document summarizes procedures for evaluating ophthalmic drug preparations. It discusses that evaluation includes sterility testing, clarity testing, leak testing, and testing for metal particles in ointments. It also describes that drug product quality tests assess attributes like identification, potency, purity, sterility and particulate matter, while performance tests evaluate drug release. Key quality tests discussed are identification, assay, pH, osmolarity, bacterial endotoxins, and uniformity of dosage units. Specific tests covered include viscosity and drop size.
This document evaluates various properties of tablets including size, shape, thickness, friability, weight variation, disintegration, and dissolution. It describes common tests used to analyze these properties, including friability testing to measure how easily tablets crumble, weight variation testing to check consistency of tablet weights, disintegration testing using glass tubes in fluid, and dissolution testing using apparatus 1 (basket type) or apparatus 2 (paddle type) to measure how quickly drugs dissolve. The document provides details on procedures, equipment, and standards used for these pharmaceutical quality control tests.
This document discusses quality control and evaluation tests for pharmaceutical aerosols. It describes tests for various components of aerosols including propellants, valves, containers, and spray characteristics. Specific tests are outlined to check properties such as weight, leaks, spray pattern, and dosage uniformity. Biological tests include evaluating therapeutic activity through particle size and determining toxicity by exposing test animals. A variety of methods are provided to analyze the flammability, physical/chemical traits, performance, and safety of pharmaceutical aerosol products.
This document evaluates different tests performed on capsules, including stability, invariability, disintegration, dissolution, and moisture permeation tests. Stability tests evaluate the integrity of the capsule shell and determine shelf life by testing shell integrity and storage conditions. Invariability tests ensure uniform weight and drug content across capsules using weight variation and content uniformity tests. Disintegration and dissolution tests measure how quickly the capsule shell breaks down and releases its drug in water or simulated gastric fluid. Moisture permeation testing verifies the suitability of packaging for preventing moisture from affecting capsules.
The document discusses preformulation studies, which involve characterizing the physical and chemical properties of a drug substance before developing a dosage form. The goals are to generate stability-indicating parameters and select an appropriate dosage form. Key topics covered include the physical properties tested (such as solubility, polymorphism, particle size), chemical degradation pathways (such as hydrolysis, oxidation), and how these properties influence dosage form design and drug performance. Understanding a drug's preformulation behavior is critical for developing a safe, effective, and stable drug product.
Capsules are solid dosage forms that contain a drug enclosed within a hard or soft soluble shell, usually made of gelatin. There are two main types: hard gelatin capsules, which consist of two pieces that are joined, and soft gelatin capsules, which have a soft, one-piece shell. Capsules offer benefits like being tasteless, odorless, and easy to administer, and allow for flexible dosing. However, some drugs are not suitable for capsules due to stability issues. Capsules are manufactured through various processes depending on the type, including dipping, spinning, drying, filling, and sealing. They must pass quality tests like weight variation and content uniformity testing.
Quality control test: Containers, Closures and Secondary packing materialsPranali Polshettiwar
This document summarizes quality control tests for containers, closures, and secondary packaging materials. It describes common materials used for each, such as glass, plastic, metal for containers and rubber, plastic, metal for closures. Key quality tests for containers include powdered glass test, water attack test, hydrolytic resistance test, and thermal shock test. Tests for closures include residue on evaporation, pH of extract, and sterility. Secondary packaging materials like paper and cardboard are also tested for quality.
The document discusses the evaluation and testing of tablets. It describes non-official tests like general appearance, organoleptic properties, size and shape, hardness, and friability. It also describes official tests like weight variation, content uniformity, dissolution, and disintegration. It discusses different types of tablets like compressed and molded tablets. It provides details on evaluating the appearance, hardness, friability and other properties of tablets and describes tests like weight variation, content uniformity, and dissolution used to ensure tablets meet specifications.
The document summarizes procedures for evaluating ophthalmic drug preparations. It discusses that evaluation includes sterility testing, clarity testing, leak testing, and testing for metal particles in ointments. It also describes that drug product quality tests assess attributes like identification, potency, purity, sterility and particulate matter, while performance tests evaluate drug release. Key quality tests discussed are identification, assay, pH, osmolarity, bacterial endotoxins, and uniformity of dosage units. Specific tests covered include viscosity and drop size.
This document evaluates various properties of tablets including size, shape, thickness, friability, weight variation, disintegration, and dissolution. It describes common tests used to analyze these properties, including friability testing to measure how easily tablets crumble, weight variation testing to check consistency of tablet weights, disintegration testing using glass tubes in fluid, and dissolution testing using apparatus 1 (basket type) or apparatus 2 (paddle type) to measure how quickly drugs dissolve. The document provides details on procedures, equipment, and standards used for these pharmaceutical quality control tests.
This document discusses quality control and evaluation tests for pharmaceutical aerosols. It describes tests for various components of aerosols including propellants, valves, containers, and spray characteristics. Specific tests are outlined to check properties such as weight, leaks, spray pattern, and dosage uniformity. Biological tests include evaluating therapeutic activity through particle size and determining toxicity by exposing test animals. A variety of methods are provided to analyze the flammability, physical/chemical traits, performance, and safety of pharmaceutical aerosol products.
This document evaluates different tests performed on capsules, including stability, invariability, disintegration, dissolution, and moisture permeation tests. Stability tests evaluate the integrity of the capsule shell and determine shelf life by testing shell integrity and storage conditions. Invariability tests ensure uniform weight and drug content across capsules using weight variation and content uniformity tests. Disintegration and dissolution tests measure how quickly the capsule shell breaks down and releases its drug in water or simulated gastric fluid. Moisture permeation testing verifies the suitability of packaging for preventing moisture from affecting capsules.
The document discusses preformulation studies, which involve characterizing the physical and chemical properties of a drug substance before developing a dosage form. The goals are to generate stability-indicating parameters and select an appropriate dosage form. Key topics covered include the physical properties tested (such as solubility, polymorphism, particle size), chemical degradation pathways (such as hydrolysis, oxidation), and how these properties influence dosage form design and drug performance. Understanding a drug's preformulation behavior is critical for developing a safe, effective, and stable drug product.
Capsules are solid dosage forms that contain a drug enclosed within a hard or soft soluble shell, usually made of gelatin. There are two main types: hard gelatin capsules, which consist of two pieces that are joined, and soft gelatin capsules, which have a soft, one-piece shell. Capsules offer benefits like being tasteless, odorless, and easy to administer, and allow for flexible dosing. However, some drugs are not suitable for capsules due to stability issues. Capsules are manufactured through various processes depending on the type, including dipping, spinning, drying, filling, and sealing. They must pass quality tests like weight variation and content uniformity testing.
Quality control test: Containers, Closures and Secondary packing materialsPranali Polshettiwar
This document summarizes quality control tests for containers, closures, and secondary packaging materials. It describes common materials used for each, such as glass, plastic, metal for containers and rubber, plastic, metal for closures. Key quality tests for containers include powdered glass test, water attack test, hydrolytic resistance test, and thermal shock test. Tests for closures include residue on evaporation, pH of extract, and sterility. Secondary packaging materials like paper and cardboard are also tested for quality.
The document discusses the evaluation and testing of tablets. It describes non-official tests like general appearance, organoleptic properties, size and shape, hardness, and friability. It also describes official tests like weight variation, content uniformity, dissolution, and disintegration. It discusses different types of tablets like compressed and molded tablets. It provides details on evaluating the appearance, hardness, friability and other properties of tablets and describes tests like weight variation, content uniformity, and dissolution used to ensure tablets meet specifications.
This document discusses hard and soft gelatin capsules. It defines capsules as solid dosage forms where the drug substance is enclosed within soluble gelatin shells. Hard gelatin capsules consist of two pieces (cap and body) while soft gelatin capsules have a single flexible shell. The document describes the production process for hard capsules including dipping, drying, and filling steps. It also discusses advantages like taste masking and disadvantages like incompatibility with hygroscopic drugs. Quality control tests for capsules include disintegration, weight variation, and dissolution testing.
Pharmaceutical aerosols have been playing a crucial role in the health and wellbeing of millions of people throughout the world for many years. These products include pressurized metered dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers, sublingual’s, skin sprays (coolants, anaesthetics, etc.) and dental sprays. The technology’s continual advancement, the ease of use, and the more desirable pulmonary-rather-than-needle delivery for systemic drugs has increased the attraction for the pharmaceutical aerosol in recent years.
Many of the tests required for the evaluation of MDIs are similar to those used for other dosage forms. These include description, identification, and assay of the active ingredient; microbial limits; moisture content; net weight, degradation products and impurities (if any); extractable; and any other tests deemed appropriate for the active ingredient.
Quality control tests for parenterals pptsuraj p rajan
This document discusses quality control tests that are performed on parenteral products. It describes 7 key tests: uniformity of content, volume of liquid, pyrogen, sterility, clarity of solution, uniformity of weight, and bacterial endotoxin. These tests ensure parenteral products meet standards for dosage uniformity, volume accuracy, freedom from fever-causing substances, freedom from microbes, visibility of solutions, weight consistency, and limits on bacterial contaminants. The tests are important for ensuring parenteral products are safe and effective for patients.
This document discusses common manufacturing defects that can occur during tablet production such as picking and sticking, capping and lamination, mottling, double impression, poor mixing, poor flow, weight variation, and hardness variation. For each defect, the document provides the reason for why the defect occurs and recommendations for how to correct the issue, such as using properly designed punches, adequate drying, uniform granule size distribution, and controlling punch movement. The overall goal of the document is to outline typical tablet defects, their causes, and methods for prevention.
The document discusses disintegration and dissolution tests for tablets. The disintegration test uses 6 glass tubes with tablets placed in baskets that move up and down in fluid to check if tablets break down within a specified time. Factors like hardness and excipients affect disintegration time. The dissolution test uses apparatus like baskets or paddles that rotate tablets in fluid to determine the drug release rate over time and ensure bioequivalence. Proper conditions like sink volume and agitation are needed. Dissolution is important to show drug availability and batch consistency.
Bio pharmaceutical classification System [BCS]Sagar Savale
The Biopharmaceutical Classification System was first developed by in 1995, by Amidon et al & his colleagues.
Definition:
“The Biopharmaceutical Classification System is a scientific framework for classifying a drug substance based on its aqueous solubility & intestinal permeability & dissolution rate”.
To saved time fast screening is required so drug substances are classified on basis of solubility and permeability. This classification is called Biopharmaceutical Classification System
This presentation summarizes various dissolution testing apparatus. It describes 7 types of apparatus recognized by USP, IP, BP and EP. The first four apparatus are commonly used and include the rotating basket, paddle, reciprocating cylinder and flow through cell. The presentation provides details on the design, working, and typical uses of each apparatus type. It also discusses commonly used dissolution media and concludes that the goal of dissolution testing is to ensure pharmaceutical quality and understand biopharmaceutical properties like rate and extent of drug absorption.
Glass as a packaging material in pharmaceutical packagingShweta Shelke
This presentation gives a brief idea about the types of glasses used in pharmaceutical industry and its intended use. Different tests used for assuring its quality for intended use.
The document provides information on quality control testing for pharmaceutical tablets. It defines quality control as the process of monitoring quality during manufacturing to ensure standards are met. It describes several important quality control tests conducted on tablets, including weight variation, thickness, hardness, friability, disintegration, dissolution, and content uniformity tests. These tests are essential to ensure tablets are safe, effective, and meet specifications for attributes like drug content, stability and patient acceptability. The document provides details on procedures, equipment and acceptance criteria for each quality control test.
quality control test for soft gelatin capsule and minim per gram factorSUJIT DAS
This document discusses quality control testing of soft gelatin capsules. Soft gelatin capsules contain an active pharmaceutical ingredient (API) encapsulated within an outer gelatin shell. They undergo various tests to check attributes like shape, size, color, thickness, leakage, disintegration, and content uniformity. Content uniformity involves weighing capsules individually, extracting the contents, weighing the shells to calculate net contents. Other tests described include disintegration testing in tubes, weight variation testing of random capsules, and factors that influence leakage like gelatin strength and viscosity.
This document discusses various visual defects that can occur during tablet processing, including capping, lamination, chipping, cracking, sticking, picking, binding, and double impression. For each defect, the document describes the causes related to formulation, processing, and machine settings, and provides potential remedies. Some common causes mentioned are insufficient or improper binders/lubricants, too dry or moist granules, deep die concavities, worn dies, and improper machine settings. Suggested remedies include modifying the formulation, drying the granules, increasing binder/lubricant amounts, adjusting machine settings, and replacing worn parts.
This document discusses large volume parenterals (LVPs), which are intravenous solutions intended for administration of more than 100 mL. It describes the characteristics, containers, labeling requirements, commonly used solutions like sodium chloride, dextrose, Ringer's solution and lactated Ringer's solution. It also discusses types of LVPs including electrolyte, carbohydrate, and nutritional solutions. Large volume parenteral containers can be plastic bags or glass bottles. Total parenteral nutrition solutions, cardioplegia solutions, peritoneal dialysis solutions, and irrigating solutions are also summarized. Formulation considerations for LVPs like drug-excipient compatibility, selection of containers, solubility of active ingredients, and pH are highlighted.
Control including pharmaceutical aspects, physical stability and packing of capsules. Capsules provide advantages such as masking taste and odor, ease of swallowing, and economical production. Quality control tests include physical tests like disintegration, weight variation and chemical tests like dissolution and content uniformity. Capsules are packaged in containers like plastic bottles or blister packs to protect from moisture and ensure stability. Pharmaceutical aspects of capsules include improved dissolution and bioavailability over tablets due to liquid fill formulations, as well as reduced gastric irritation potential.
Granulation process may be defined as a process wherein small particles adhere together by forming bonds between them , resulting in the formation of large aggregates called granules.
This document discusses tablet tooling and the tablet compression process. It describes the main types of tablet tooling, including 'B', 'D', 'BB', and 'DB' tooling, and provides their dimensions and specifications. It also outlines the basic components of a tablet press, including the hopper, dies, punches, cam tracks, and feeding mechanism. Finally, it explains the three main steps of the tablet compression process: filling and dosing the dies, compressing the tablets, and ejecting and exiting the tablets from the press.
Pharmaceutical aerosols are therapeutic active ingredients packaged in a pressurized system. They have advantages like direct delivery to affected areas without contamination. Aerosols consist of a propellant, container, valve, and product concentrate. Common propellants include hydrocarbons and gases. Containers must withstand high pressure and are often metal or glass. Valves meter doses and come in types like spray or foam. Formulations contain an active ingredient and propellant to achieve desired properties. Quality is ensured through testing of components, dosage, leakage and other parameters.
Parenterals are the sterile preparation that is directly administered into the circulatory system avoiding the enteral route. And these preparation provide rapid onset of action that is why the administered preparation must be safe.
Stability problem arise from microbial contamination of these products so sterility and stability must be ensured for these preparations.
To ensure their sterility and stability, regulations regarding to quality control through pharmacopeial specifications has great importance.
This document discusses the formulation and evaluation of calcium alginate beads loaded with diclofenac sodium. The objective is to develop an extended release dosage form of diclofenac sodium to reduce dosing frequency and improve patient compliance by maintaining therapeutic drug levels. Calcium alginate beads are prepared using an ionotropic gelation method by dropping sodium alginate solution containing diclofenac sodium into calcium chloride solution, resulting in crosslinking and formation of beads. The beads are evaluated for drug release using dissolution studies.
This document summarizes parenterals and their quality control testing. Parenterals are sterile dosage forms intended for administration other than orally that enter systemic circulation. Their advantages include quick onset, suitability for non-oral drugs, and use in emergencies. Disadvantages are the need for trained personnel and risks of pain, sensitivity, and expense. Quality control tests described include content uniformity, leakers, pyrogens, sterility, and particulates. Specific test methods and acceptance criteria are provided to ensure parenterals meet quality standards.
This document discusses preformulation studies and biopharmaceutical classification system (BCS) classification. It provides an introduction to preformulation studies, which characterize the physical and chemical properties of drug substances alone and with excipients. The goals and types of preformulation studies are described. Key parameters evaluated in preformulation studies include physical characteristics, chemical characteristics, organoleptic properties, polymorphism, particle size and shape, powder flow properties, hygroscopicity, solubility, pH solubility profile and common ion effects, dissolution, and permeability. Methods for various preformulation tests are also outlined.
In Process Quality Control Tests For Capsules [Autosaved].pptxSurendra Chowdary
This document discusses in-process quality control tests for capsules. It describes 7 types of tests: 1) Stability tests like shell integrity and shelf life determination, 2) Purity tests of the capsule shell, 3) Invariability tests like weight variation and content uniformity, 4) Disintegration testing, 5) Dissolution testing, 6) Moisture permeation testing of packaging, and 7) Batch release tests. The document provides details on the procedures and acceptance criteria for each of these quality control tests performed on capsules during manufacturing.
1. The document discusses in-process quality control (IPQC) and finished product quality control (FPQC) tests for pharmaceutical capsules according to various pharmacopoeias. It describes 12 key tests including appearance, size, assay, content uniformity, dissolution, and stability testing.
2. The tests evaluate physical parameters like temperature, humidity, weight, and disintegration time. They also assess the content of active ingredients and whether capsules meet specifications for content uniformity, dissolution rate, and stability over time.
3. Ensuring quality through comprehensive testing during and after production is important for regulatory compliance and producing safe, effective pharmaceuticals. The various pharmacopoeias have different standards and requirements but collectively
This document discusses hard and soft gelatin capsules. It defines capsules as solid dosage forms where the drug substance is enclosed within soluble gelatin shells. Hard gelatin capsules consist of two pieces (cap and body) while soft gelatin capsules have a single flexible shell. The document describes the production process for hard capsules including dipping, drying, and filling steps. It also discusses advantages like taste masking and disadvantages like incompatibility with hygroscopic drugs. Quality control tests for capsules include disintegration, weight variation, and dissolution testing.
Pharmaceutical aerosols have been playing a crucial role in the health and wellbeing of millions of people throughout the world for many years. These products include pressurized metered dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers, sublingual’s, skin sprays (coolants, anaesthetics, etc.) and dental sprays. The technology’s continual advancement, the ease of use, and the more desirable pulmonary-rather-than-needle delivery for systemic drugs has increased the attraction for the pharmaceutical aerosol in recent years.
Many of the tests required for the evaluation of MDIs are similar to those used for other dosage forms. These include description, identification, and assay of the active ingredient; microbial limits; moisture content; net weight, degradation products and impurities (if any); extractable; and any other tests deemed appropriate for the active ingredient.
Quality control tests for parenterals pptsuraj p rajan
This document discusses quality control tests that are performed on parenteral products. It describes 7 key tests: uniformity of content, volume of liquid, pyrogen, sterility, clarity of solution, uniformity of weight, and bacterial endotoxin. These tests ensure parenteral products meet standards for dosage uniformity, volume accuracy, freedom from fever-causing substances, freedom from microbes, visibility of solutions, weight consistency, and limits on bacterial contaminants. The tests are important for ensuring parenteral products are safe and effective for patients.
This document discusses common manufacturing defects that can occur during tablet production such as picking and sticking, capping and lamination, mottling, double impression, poor mixing, poor flow, weight variation, and hardness variation. For each defect, the document provides the reason for why the defect occurs and recommendations for how to correct the issue, such as using properly designed punches, adequate drying, uniform granule size distribution, and controlling punch movement. The overall goal of the document is to outline typical tablet defects, their causes, and methods for prevention.
The document discusses disintegration and dissolution tests for tablets. The disintegration test uses 6 glass tubes with tablets placed in baskets that move up and down in fluid to check if tablets break down within a specified time. Factors like hardness and excipients affect disintegration time. The dissolution test uses apparatus like baskets or paddles that rotate tablets in fluid to determine the drug release rate over time and ensure bioequivalence. Proper conditions like sink volume and agitation are needed. Dissolution is important to show drug availability and batch consistency.
Bio pharmaceutical classification System [BCS]Sagar Savale
The Biopharmaceutical Classification System was first developed by in 1995, by Amidon et al & his colleagues.
Definition:
“The Biopharmaceutical Classification System is a scientific framework for classifying a drug substance based on its aqueous solubility & intestinal permeability & dissolution rate”.
To saved time fast screening is required so drug substances are classified on basis of solubility and permeability. This classification is called Biopharmaceutical Classification System
This presentation summarizes various dissolution testing apparatus. It describes 7 types of apparatus recognized by USP, IP, BP and EP. The first four apparatus are commonly used and include the rotating basket, paddle, reciprocating cylinder and flow through cell. The presentation provides details on the design, working, and typical uses of each apparatus type. It also discusses commonly used dissolution media and concludes that the goal of dissolution testing is to ensure pharmaceutical quality and understand biopharmaceutical properties like rate and extent of drug absorption.
Glass as a packaging material in pharmaceutical packagingShweta Shelke
This presentation gives a brief idea about the types of glasses used in pharmaceutical industry and its intended use. Different tests used for assuring its quality for intended use.
The document provides information on quality control testing for pharmaceutical tablets. It defines quality control as the process of monitoring quality during manufacturing to ensure standards are met. It describes several important quality control tests conducted on tablets, including weight variation, thickness, hardness, friability, disintegration, dissolution, and content uniformity tests. These tests are essential to ensure tablets are safe, effective, and meet specifications for attributes like drug content, stability and patient acceptability. The document provides details on procedures, equipment and acceptance criteria for each quality control test.
quality control test for soft gelatin capsule and minim per gram factorSUJIT DAS
This document discusses quality control testing of soft gelatin capsules. Soft gelatin capsules contain an active pharmaceutical ingredient (API) encapsulated within an outer gelatin shell. They undergo various tests to check attributes like shape, size, color, thickness, leakage, disintegration, and content uniformity. Content uniformity involves weighing capsules individually, extracting the contents, weighing the shells to calculate net contents. Other tests described include disintegration testing in tubes, weight variation testing of random capsules, and factors that influence leakage like gelatin strength and viscosity.
This document discusses various visual defects that can occur during tablet processing, including capping, lamination, chipping, cracking, sticking, picking, binding, and double impression. For each defect, the document describes the causes related to formulation, processing, and machine settings, and provides potential remedies. Some common causes mentioned are insufficient or improper binders/lubricants, too dry or moist granules, deep die concavities, worn dies, and improper machine settings. Suggested remedies include modifying the formulation, drying the granules, increasing binder/lubricant amounts, adjusting machine settings, and replacing worn parts.
This document discusses large volume parenterals (LVPs), which are intravenous solutions intended for administration of more than 100 mL. It describes the characteristics, containers, labeling requirements, commonly used solutions like sodium chloride, dextrose, Ringer's solution and lactated Ringer's solution. It also discusses types of LVPs including electrolyte, carbohydrate, and nutritional solutions. Large volume parenteral containers can be plastic bags or glass bottles. Total parenteral nutrition solutions, cardioplegia solutions, peritoneal dialysis solutions, and irrigating solutions are also summarized. Formulation considerations for LVPs like drug-excipient compatibility, selection of containers, solubility of active ingredients, and pH are highlighted.
Control including pharmaceutical aspects, physical stability and packing of capsules. Capsules provide advantages such as masking taste and odor, ease of swallowing, and economical production. Quality control tests include physical tests like disintegration, weight variation and chemical tests like dissolution and content uniformity. Capsules are packaged in containers like plastic bottles or blister packs to protect from moisture and ensure stability. Pharmaceutical aspects of capsules include improved dissolution and bioavailability over tablets due to liquid fill formulations, as well as reduced gastric irritation potential.
Granulation process may be defined as a process wherein small particles adhere together by forming bonds between them , resulting in the formation of large aggregates called granules.
This document discusses tablet tooling and the tablet compression process. It describes the main types of tablet tooling, including 'B', 'D', 'BB', and 'DB' tooling, and provides their dimensions and specifications. It also outlines the basic components of a tablet press, including the hopper, dies, punches, cam tracks, and feeding mechanism. Finally, it explains the three main steps of the tablet compression process: filling and dosing the dies, compressing the tablets, and ejecting and exiting the tablets from the press.
Pharmaceutical aerosols are therapeutic active ingredients packaged in a pressurized system. They have advantages like direct delivery to affected areas without contamination. Aerosols consist of a propellant, container, valve, and product concentrate. Common propellants include hydrocarbons and gases. Containers must withstand high pressure and are often metal or glass. Valves meter doses and come in types like spray or foam. Formulations contain an active ingredient and propellant to achieve desired properties. Quality is ensured through testing of components, dosage, leakage and other parameters.
Parenterals are the sterile preparation that is directly administered into the circulatory system avoiding the enteral route. And these preparation provide rapid onset of action that is why the administered preparation must be safe.
Stability problem arise from microbial contamination of these products so sterility and stability must be ensured for these preparations.
To ensure their sterility and stability, regulations regarding to quality control through pharmacopeial specifications has great importance.
This document discusses the formulation and evaluation of calcium alginate beads loaded with diclofenac sodium. The objective is to develop an extended release dosage form of diclofenac sodium to reduce dosing frequency and improve patient compliance by maintaining therapeutic drug levels. Calcium alginate beads are prepared using an ionotropic gelation method by dropping sodium alginate solution containing diclofenac sodium into calcium chloride solution, resulting in crosslinking and formation of beads. The beads are evaluated for drug release using dissolution studies.
This document summarizes parenterals and their quality control testing. Parenterals are sterile dosage forms intended for administration other than orally that enter systemic circulation. Their advantages include quick onset, suitability for non-oral drugs, and use in emergencies. Disadvantages are the need for trained personnel and risks of pain, sensitivity, and expense. Quality control tests described include content uniformity, leakers, pyrogens, sterility, and particulates. Specific test methods and acceptance criteria are provided to ensure parenterals meet quality standards.
This document discusses preformulation studies and biopharmaceutical classification system (BCS) classification. It provides an introduction to preformulation studies, which characterize the physical and chemical properties of drug substances alone and with excipients. The goals and types of preformulation studies are described. Key parameters evaluated in preformulation studies include physical characteristics, chemical characteristics, organoleptic properties, polymorphism, particle size and shape, powder flow properties, hygroscopicity, solubility, pH solubility profile and common ion effects, dissolution, and permeability. Methods for various preformulation tests are also outlined.
In Process Quality Control Tests For Capsules [Autosaved].pptxSurendra Chowdary
This document discusses in-process quality control tests for capsules. It describes 7 types of tests: 1) Stability tests like shell integrity and shelf life determination, 2) Purity tests of the capsule shell, 3) Invariability tests like weight variation and content uniformity, 4) Disintegration testing, 5) Dissolution testing, 6) Moisture permeation testing of packaging, and 7) Batch release tests. The document provides details on the procedures and acceptance criteria for each of these quality control tests performed on capsules during manufacturing.
1. The document discusses in-process quality control (IPQC) and finished product quality control (FPQC) tests for pharmaceutical capsules according to various pharmacopoeias. It describes 12 key tests including appearance, size, assay, content uniformity, dissolution, and stability testing.
2. The tests evaluate physical parameters like temperature, humidity, weight, and disintegration time. They also assess the content of active ingredients and whether capsules meet specifications for content uniformity, dissolution rate, and stability over time.
3. Ensuring quality through comprehensive testing during and after production is important for regulatory compliance and producing safe, effective pharmaceuticals. The various pharmacopoeias have different standards and requirements but collectively
Hardness, friability, thickness, disintegration, weight variation, content uniformity, and dissolution are important quality control tests conducted on tablets. Hardness ensures tablets can withstand handling and processing, while friability measures how well tablets withstand abrasion. Disintegration tests how long it takes for tablets to break down, and weight variation and content uniformity ensure all tablets contain the intended amount of active drug. Dissolution testing determines how quickly the drug is released from the tablet in the body. Documentation of all quality control test results is necessary.
This document discusses important quality control tests that are conducted on tablets during production. It outlines tests for hardness, friability, thickness, disintegration, weight variation, content uniformity, dissolution, and leak testing of packaging. Specific procedures and acceptance criteria are provided for each test to ensure the tablets meet standards for quality, stability, and ability to deliver the intended dose of medication. Routine quality control testing plays a key role in pharmaceutical manufacturing.
In process & finished products quality control test of capsuleArpitSuralkar
This document discusses quality control tests for pharmaceutical capsules that are performed during the manufacturing process (IPQC tests) and on finished products (FPQC tests). It provides details on various physical parameters tested by IPQC like temperature, humidity, weight variation. FPQC tests include assays, dissolution testing, stability testing, and ensuring uniform drug content between capsules. The document outlines specific test methods and acceptance criteria from pharmacopeias for tests like disintegration, dissolution and content uniformity. It emphasizes that quality testing helps ensure capsules meet regulatory standards and provides maximum safety for human health.
IPQC Tests for capsules As per IP, BP & USPPramod Ramane
IPQC- In Process Quality Control Tests for Capsules are
1. Uniformity Of Content
2. Disintigration Test
3. Weight Variation Test
4. Dissolution Test
The tests are with Acceptance limits/Criteria as per Indian Pharmacopoeia (IP), British Pharmacopoeia (BP) & United States Pharmacopoeia (USP)
Quality control tests ensure tablets meet specifications for drug content, release properties, and physical characteristics. The document outlines official quality control tests from pharmacopeias including uniformity of content to ensure consistent drug dose between tablets, dissolution testing to ensure controlled drug release, and disintegration testing to confirm tablets break down within defined limits. Additional common tests described are hardness, thickness, and friability testing to ensure tablets can withstand manufacturing and handling forces. Special tests are specified for effervescent, soluble, and enteric coated tablets tailored to their drug release mechanisms.
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)Gaurav kumar
This presentation pertains to the in-process tests performed during the manufacturing process of the solid dosages form (tablets).
The presentation covers the methods and the permissible limits for the tests performed.
These tests are of great importance as these not only ensure quality product but also upholds the cGMP.
IPQC is concerned with providing accurate , specific, & definite descriptions of the procedures to be employed, from, the receipt of raw materials to the release of the finished dosage forms
In process stability control test for capsuleJinendra Jain
This document discusses quality control testing for capsules. It describes physical tests like disintegration testing, weight variation testing, and chemical tests like dissolution testing and content uniformity testing. Disintegration testing ensures capsules break down within a specified time in liquid. Weight variation testing checks that capsule weights are consistent. Dissolution testing measures how quickly the active drug is released. Content uniformity testing confirms the amount of drug in each capsule is consistent. These quality control tests are important to ensure capsules meet specifications and perform as intended.
Capsules come in both hard and soft gelatin shells that enclose solid or liquid medications. Quality control tests are conducted on empty capsules and finished capsules to ensure uniformity of weight, content of active ingredients, and dissolution. Key tests include uniformity of weight, content of active ingredients, and uniformity of content. Acceptance criteria vary slightly between pharmacopeias but generally require less than 10% deviation from the average weight and 90-110% of the average active content. In-process quality checks are also important to monitor production and identify defects.
IN-PROCESS QUALITY CONTROL TESTS - IPQC OF TABLETS pptAkanksha Puri
1) In-process quality control (IPQC) tests are tests conducted during the manufacturing process to monitor quality and make adjustments if needed to comply with specifications. Some key IPQC tests for tablets include weight variation, hardness, friability, disintegration, and dissolution.
2) Important reasons for IPQC testing include minimizing human error, providing accurate manufacturing procedures, easier identification of problems, and immediately addressing quality issues. IPQC helps ensure product quality.
3) Common types of IPQC tests include physical and chemical tests, biological and microbiological tests, and tests for identity, purity, potency, and quality. Official IPQC tests specified for tablets are weight variation, disintegration, dissolution, and drug content
Non sterile manufacturing process technologyPRANJAY PATIL
This document provides an overview of in-process quality control (IPQC) tests for non-sterile pharmaceutical tablets and capsules. It discusses the importance of IPQC in minimizing errors and enforcing manufacturing standards. Common IPQC tests described for tablets include weight variation, content uniformity, hardness, thickness, friability, dissolution, disintegration, and moisture content. For capsules, discussed tests include content of active ingredients, weight variation, content uniformity, disintegration, and dissolution. A variety of apparatus used in conducting these tests are also outlined.
Non sterile manufacturing process technologyPRANJAY PATIL
This document provides an overview of in-process quality control (IPQC) tests for tablets and capsules during the manufacturing process. It discusses the importance and scope of IPQC, as well as general IPQC tests such as identity, quality, purity, and potency tests. Specific IPQC tests covered for tablets include weight variation, content uniformity, hardness, thickness, friability, dissolution, disintegration, and moisture content. For capsules, content of active ingredients, weight variation, content uniformity, disintegration, dissolution, and moisture permeation are discussed. Various apparatus used to perform these tests are also described.
This document provides information about tablets, including their definition, categories, in-process tests, and testing methods. Tablets are solid oral dosage forms containing medicaments. There are several categories including uncoated, film coated, sugar coated, and modified release tablets. In-process tests include uniformity of contents, weight, dissolution, and disintegration. Dissolution and disintegration tests are described for different tablet types using specified apparatus, media, and time/acceptance criteria. Modified and prolonged release tablets have additional dissolution testing methods and criteria for acid and buffer stages.
IPQC checks are carried out during the manufacturing process to monitor critical variables that can impact product quality. In-process materials are tested for identity, strength, and purity, and any rejected materials are quarantined. The objectives are quality control, process control, and ensuring final product quality through continuous monitoring and implementation of good manufacturing practices. IPQC involves establishing and documenting controls to ensure output falls within acceptable standard ranges.
IPQC tests are important quality control checks performed during the manufacturing of tablets, capsules, and ointments. For tablets, key tests include weight variation, disintegration, dissolution, drug content, hardness, and friability. Tests for capsules include uniformity of content, disintegration, weight variation, and dissolution. Common tests for ointments are not described. IPQC aims to detect errors, minimize human error, and ensure quality at each stage of production according to established procedures.
In Process Quality Control Tests (IPQC) for Solid Dosage FromSagar Savale
This document discusses in-process quality control tests that are performed during the manufacturing of solid oral dosage forms such as tablets and capsules. It provides details about common tests like weight variation, hardness, friability, disintegration and dissolution. The tests help to identify any issues during production so that corrective actions can be taken. Specific test methods, acceptance criteria and instruments used for tests are outlined for various types of oral dosage forms including immediate release tablets, sustained release tablets, capsules and suppositories. Maintaining quality during manufacturing is important to deliver consistent drug levels in patients.
2. Quality Control of Solid Dosage Forms.pptxashfaq22
This document discusses quality control tests for solid oral dosage forms, specifically tablets. It describes common physical tests like weight variation, hardness, thickness and diameter, friability, and disintegration time. It also covers important chemical tests like assay, content uniformity, and dissolution. Test procedures and acceptance criteria are provided for each test. Different test procedures are described for uncoated, coated, enteric-coated, buccal, and sublingual tablets. A variety of apparatus and equipment used in the tests are also illustrated.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
2. Evaluation of Capsule
Capsules are evaluated by the following tests:
1. Weight Variation Test
2. Content Uniformity Test
3. Dissolution Test
4. Disintegration Test
5. Leak Test
3. Weight Variation Test
Procedure;
Weight variation test is carried out by weighing 20 capsules individually using analytical balance,
then calculating the average mass and comparing the individual tablet mass to the average.
The mass of each capsule should be within ±10% of the average mass. If all the capsules do not
fall within these limits, weigh the 20 capsules again, taking care to preserve the identity of each
capsule, and remove the contents as completely as possible.
For soft gelatin capsules, wash the shell with ether or some other suitable solvent and allow it to
stand until the odour of the solvent is no longer perceptible. Other means, such as a jet of
compressed air, may be used to remove the contents.
Weigh the emptied shells individually and calculate for each capsule the net mass of its contents
by subtracting the mass of the shell from the gross mass. Determine the average net content from
the sum of the individual net masses.
4. Then determine the difference between each individual net content and the average
net content. Deviation of individual net mass from the average net mass should not
exceed the limits given below.
Table:IP, BP and phEur limits for uniformity of weight :
Average mass (mg) Percentage deviation(%)
Less than 300 ±10%
More than 300 ±7.5%
5. Table : PhInt limits for uniformity of weight
Net mass(mg) Percentage
deviation(%)
Number of capsules
Less than 300 ±10% Minimum 18
±20% Maximum 2
More than 300 ±7.5% Minimum 18
±15% Maximum 2
6. 2.Contents uniformity test
Procedure:
In the official test 30 capsules are selected and 10 of these are assayed
individually.The requirements are met if 9 of the 10 are within the specified
potency range of 85 to 115 %, and the tenth is not outside 75 to 125 %.
If more than 1, but less than 3, of the first 10 capsules fall out side the 85 to 115
% limits, the remaining 20 are assayed The requirements are met if all 30
capsules are with in 75 to 125 % of the specified potency range, and not less than
27 of the 30 are within the 85 to 115% range.
7. 3. Dissolution Test
Dissolution Test is an official method to determine the dissolution rate of a solid dosage
from.There are currently four dissolution apparatus described in the US and European
Pharmacopoeias for the testing of oral solid drug products. These are the basket and
paddle apparatus, the reciprocating cylinder and the flow through cell .
Procedure :
1. The capsules is placed in a basket and the basket is immersed in the dissolution
medium and caused to rotate at a specified speed
2. The dissolution mediums is held in a covered 1000ml glass vessel and maintained at
37±0.5°C by means of a constant temperature suitable water bath
3. The stirred speed and type of dissolution mediums are specified in individuals
monograph.
8. BP, USP, PhEur, PhInt and JP acceptance criteria for dissolution test of capsule is shown in
the table below :
Stage No. Of Capsule tested Acceptance Criteria
S1 6 Each unit is not less than
Q+5%
S2 6 Average of 12 units (S1+S2) is
equal to or greater than Q and
no unit is not less than Q-15%
S3 12 Average of 24 units
(S1+S2+S3) is equal to or
greater than Q, not less than 2
units are less Q-15% and no
unit is less than Q-25%
9.
10. Disintegration Test
Procedure :
The USP disintegration apparatus consist of 6 glass tubes that are 3 inches long,
open at the top, and held against a 10-mesh screen at the
bottom end of the basket rack assembly.
To test for disintegration time, one capsule is placed in each tube and the basket
rack is positioned in specified medium at 37±2ºC such that capsule remains 2.5
cm below the surface of the liquid on their upward movement and descend not
closer than 2.5 cm from the bottom of the beaker. A standard motor driven device
is used to move the basket assembly containing the capsules up and down through
distance of 5 to 6 cm at a frequency of 28 to 32 cycles per minute. Operate the
apparatus for the specified time.
11. The capsule complies with the test according to USP, if all of the capsules have
disintegrated completely. If 1 or 2 capsules fail to disintegrate completely, repeat the
test on 12 additional capsules. The requirement is met if not less than 16 of the total of
18 capsules tested are disintegrated.
Disintegration time of various capsules according to BP is given below :
Capsules Disintegration Time (min)
Hard capsules 30
Soft capsules 30
Rectal capsules 30
Vaginal Capsules 30
Gastroresistance Capsules 60
12. 5)Leak test
Procedure(PT-LT apparatus):
Samples are placed into the desiccator’s housing and the lid is placed in position. The
pump starts to produce a vacuum inside the desiccator and the sample is held for a pre-
set time. After the test, the tested package should keep its shape indicating a good seal.
It is also possible to use a colored dye solution (normally Methylene Blue). If there are
any holes in the seal, the dye penetrates the contents of the packaging.